Eloxx Pharmaceuticals Inc
F:3970
Income Statement
Earnings Waterfall
Eloxx Pharmaceuticals Inc
Income Statement
Eloxx Pharmaceuticals Inc
| Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+100%
|
0
+50%
|
0
+33%
|
0
-25%
|
0
-33%
|
0
-50%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(5)
|
(5)
|
(6)
|
(7)
|
(8)
|
(9)
|
(8)
|
(8)
|
(6)
|
(4)
|
(5)
|
(5)
|
(7)
|
(7)
|
(6)
|
(5)
|
(3)
|
(20)
|
(28)
|
(41)
|
(52)
|
(47)
|
(51)
|
(52)
|
(53)
|
(51)
|
(48)
|
(46)
|
(39)
|
(29)
|
(28)
|
(56)
|
(60)
|
(66)
|
(68)
|
(43)
|
(40)
|
(34)
|
(29)
|
(23)
|
(19)
|
|
| Selling, General & Administrative |
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(3)
|
(3)
|
(2)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(4)
|
(7)
|
(16)
|
(22)
|
(26)
|
(29)
|
(26)
|
(26)
|
(25)
|
(24)
|
(21)
|
(18)
|
(15)
|
(14)
|
(17)
|
(19)
|
(20)
|
(19)
|
(14)
|
(12)
|
(11)
|
(10)
|
(9)
|
(9)
|
|
| Research & Development |
(2)
|
(2)
|
(3)
|
(3)
|
(5)
|
(5)
|
(5)
|
(5)
|
(3)
|
(2)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(16)
|
(21)
|
(25)
|
(30)
|
(20)
|
(22)
|
(25)
|
(27)
|
(26)
|
(24)
|
(21)
|
(17)
|
(15)
|
(14)
|
(39)
|
(41)
|
(46)
|
(49)
|
(29)
|
(28)
|
(24)
|
(19)
|
(14)
|
(10)
|
|
| Depreciation & Amortization |
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(3)
|
(4)
|
(3)
|
(3)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(5)
N/A
|
(5)
-6%
|
(6)
-21%
|
(7)
-10%
|
(8)
-19%
|
(9)
-13%
|
(8)
+10%
|
(8)
+9%
|
(6)
+23%
|
(4)
+28%
|
(5)
-16%
|
(5)
-10%
|
(7)
-23%
|
(7)
-8%
|
(6)
+22%
|
(5)
+16%
|
(3)
+36%
|
(20)
-577%
|
(28)
-37%
|
(41)
-47%
|
(52)
-26%
|
(47)
+9%
|
(51)
-9%
|
(52)
-1%
|
(53)
-3%
|
(51)
+5%
|
(48)
+4%
|
(46)
+6%
|
(39)
+14%
|
(29)
+25%
|
(28)
+5%
|
(56)
-100%
|
(60)
-7%
|
(66)
-10%
|
(68)
-3%
|
(43)
+37%
|
(40)
+6%
|
(34)
+14%
|
(29)
+16%
|
(23)
+21%
|
(19)
+15%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
1
|
0
|
(1)
|
(2)
|
(0)
|
0
|
0
|
0
|
1
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
1
|
1
|
1
|
(2)
|
(4)
|
(12)
|
(12)
|
(10)
|
(8)
|
(3)
|
(6)
|
(6)
|
(6)
|
(3)
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
(4)
|
(0)
|
(0)
|
1
|
1
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Total Other Income |
0
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
1
|
1
|
(1)
|
(1)
|
(1)
|
0
|
1
|
1
|
3
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(6)
N/A
|
(6)
-6%
|
(7)
-21%
|
(9)
-23%
|
(13)
-37%
|
(22)
-72%
|
(21)
+4%
|
(18)
+13%
|
(13)
+28%
|
(6)
+53%
|
(8)
-36%
|
(9)
-6%
|
(10)
-16%
|
(8)
+26%
|
(6)
+18%
|
(7)
-9%
|
(7)
+4%
|
(21)
-224%
|
(28)
-31%
|
(39)
-41%
|
(49)
-25%
|
(47)
+4%
|
(50)
-7%
|
(51)
-2%
|
(53)
-3%
|
(51)
+4%
|
(53)
-4%
|
(46)
+12%
|
(40)
+14%
|
(35)
+14%
|
(29)
+15%
|
(57)
-96%
|
(61)
-6%
|
(67)
-10%
|
(70)
-4%
|
(44)
+37%
|
(42)
+5%
|
(36)
+14%
|
(31)
+15%
|
(24)
+20%
|
(20)
+16%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(6)
|
(6)
|
(7)
|
(9)
|
(13)
|
(22)
|
(21)
|
(18)
|
(13)
|
(6)
|
(8)
|
(8)
|
(9)
|
(6)
|
(5)
|
(6)
|
(6)
|
(21)
|
(28)
|
(39)
|
(49)
|
(47)
|
(51)
|
(52)
|
(53)
|
(51)
|
(53)
|
(46)
|
(40)
|
(35)
|
(29)
|
(57)
|
(61)
|
(67)
|
(70)
|
(44)
|
(42)
|
(36)
|
(31)
|
(24)
|
(20)
|
|
| Net Income (Common) |
(6)
N/A
|
(6)
-6%
|
(10)
-63%
|
(14)
-32%
|
(17)
-24%
|
(26)
-53%
|
(23)
+14%
|
(19)
+16%
|
(14)
+26%
|
(7)
+49%
|
(9)
-26%
|
(8)
+6%
|
(9)
-7%
|
(6)
+34%
|
(5)
+17%
|
(6)
-24%
|
(7)
-7%
|
(24)
-256%
|
(30)
-28%
|
(41)
-37%
|
(51)
-24%
|
(47)
+7%
|
(51)
-7%
|
(52)
-2%
|
(53)
-3%
|
(51)
+5%
|
(53)
-4%
|
(46)
+12%
|
(40)
+14%
|
(35)
+14%
|
(29)
+15%
|
(57)
-96%
|
(61)
-6%
|
(67)
-10%
|
(70)
-4%
|
(44)
+37%
|
(42)
+5%
|
(36)
+14%
|
(31)
+15%
|
(24)
+20%
|
(20)
+16%
|
|
| EPS (Diluted) |
-50.75
N/A
|
-37.88
+25%
|
-36.1
+5%
|
-51.29
-42%
|
-24.98
+51%
|
-37.12
-49%
|
-32.25
+13%
|
-26.25
+19%
|
-14.03
+47%
|
-7
+50%
|
-8.81
-26%
|
-8.28
+6%
|
-8.87
-7%
|
-5.82
+34%
|
-4.22
+27%
|
-5.34
-27%
|
-3.2
+40%
|
-4.75
-48%
|
-1.09
+77%
|
-1.29
-18%
|
-1.45
-12%
|
-1.45
N/A
|
-1.4
+3%
|
-1.42
-1%
|
-1.33
+6%
|
-1.34
-1%
|
-1.32
+1%
|
-1.16
+12%
|
-1
+14%
|
-0.86
+14%
|
-0.73
+15%
|
-0.86
-18%
|
-28.19
-3 178%
|
-38.15
-35%
|
-32.15
+16%
|
-20.4
+37%
|
-19.32
+5%
|
-16.65
+14%
|
-14.16
+15%
|
-11.02
+22%
|
-7.45
+32%
|
|